FM Compounders Equity ETF Price & Performance (FMCE)

Atria Wealth Solutions Inc. has invested $208,000 in the Harbor International Compounders ETF, acquiring 8,035 shares during the fourth quarter. This move aligns with broader institutional interest in the fund, which targets international growth companies using ESG criteria. The ETF's market cap stands at $324.27 million, with a P/E ratio of 25.43.1

Shares of Hims & Hers Health fell over 23% after the FDA announced the resolution of a semaglutide shortage. Semaglutide, a key ingredient in popular weight-loss drugs, was compounded by Hims & Hers during the shortage. The FDA plans to enforce stricter regulations on such practices soon, impacting compounding pharmacies.2

Hims & Hers, which saw significant stock gains last year, faces challenges as the FDA ends the semaglutide shortage and tightens regulations. Despite this, the company continues to expand, acquiring a peptide facility and at-home lab testing service to enhance its personalized medication offerings and pre-treatment capabilities.2